Floatz logo

FLUOROURACILUM

PD-L1

Zhejiang Provincial People's HospitalSmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the PD-L1 cohort.

Asset / SponsorPhaseRating
Eloxatin
Zhejiang Provincial People's Hospital
Phase 1/2CC
Irinotecan
Zhejiang Provincial People's Hospital
Phase 1/2CC
Calcium folinate pentahydrate
Zhejiang Provincial People's Hospital
Phase 1/2CC

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →